Breaking News Instant updates and real-time market news.

WBA

Walgreens Boots Alliance

$55.11

2.71 (5.17%)

14:43
06/27/19
06/27
14:43
06/27/19
14:43

Walgreens Boots Alliance Q3 better than expected, says Raymond James

Raymond James analyst John Ransom maintained a Market Perform rating on Walgreens Boots Alliance after the company reported Q3 earnings results that were modestly better than expected, driven by strong pharmacy sales, along with "roughly flat" FY19 guidance which the analyst believes reflects ongoing headwinds from reimbursement and market challenges.

  • 27

    Jun

WBA Walgreens Boots Alliance
$55.11

2.71 (5.17%)

04/18/19
04/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Morgan Stanley (MS) downgraded to Neutral from Buy at Citi with analyst Keith Horowitz saying Morgan Stanley reported "strong" Q1 results but the shares are fairly valued. 2. Snap (SNAP) downgraded to Negative from Mixed at Vertical Group and to Neutral from Outperform at Wedbush. 3. Rite Aid (RAD) downgraded with a Sell from Neutral at Guggenheim while Walgreens Boots Alliance (WBA) was downgraded with a Neutral from Buy. 4. CF Industries (CF) downgraded to Underperform from Buy at BofA/Merrill with analyst Steve Byrne saying he has spoken with 10 key channel contacts in the Cornbelt and several commented that never in their 30-plus year careers have they seen fertilizer applications this far behind, mainly due to the weather. 5. FMC Corporation (FMC) downgraded to Sector Perform from Outperform at RBC Capital with analyst Arun Viswanathan citing the "uncertainty of Rynaxypyr and Cyazypyr patent expiration" as well as the reduced multiple from the recent lithium separation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/25/19
BARD
04/25/19
NO CHANGE
Target $336
BARD
Outperform
Smile Direct, CVS news 'good' for Align Technology, says Baird
Smile Direct Club announced an expanded agreement with CVS (CVS) and an agreement with Aetna Dental, which Baird analyst Jeff Johnson could likely drive additional clear aligner awareness, something that should be good for the industry, and, specifically Align Technology (ALGN), where early efforts with Walgreens (WBA) "seem to be developing" and where traction remains strong through DSOs. The analyst maintains an Outperform rating and $336 price target on Align Technology shares.
04/25/19
DESJ
04/25/19
INITIATION
DESJ
Buy
Desjardins initiates HEXO Corp, Canopy Growth, Aurora Cannabis with a Buy
Desjardins analyst John Chu initiated HEXO Corp (HEXO), Canopy Growth (CGC), and Aurora Cannabis (ACB) with a Buy rating and respective price targets of C$14, C$74, and C$16.50 as part of a broad research note, saying the "hype" around legalization of adult-use cannabis in Canada remains strong in spite of "underwhelming" early months of sales. The analyst attributes the challenges to ramp-up, logistical and distribution issues, but expects investors to consider the opportunity as a "global" one. Chu believes that "major" consumer packaged goods companies like Constellation (STZ), InBev (BUD), and Altria (MO), as well as retailers like Walgreens (WBA), CVS (CVS), and Rite Aid (RAD) should "help push cannabis and hemp into the mainstream."
05/14/19
RAJA
05/14/19
NO CHANGE
RAJA
Walgreens could target Amerisource, LabCorp if it seeks M&A, says Raymond James
Raymond James analyst John Ransom said he thinks that "the temptation" for Walgreens (WBA) to do "something" in terms of M&A will grow over time and the "something" it may consider could include either acquiring AmerisourceBergen (ABC) or LabCorp (LH). His analysis points to LabCorp being a less complicated, "but much less accretive," deal, said Ransom. Given Walgreens' existing ownership of about a 26% stake in AmerisourceBergen, he estimates 16% accretion from buying the company for $95 per share in cash if he assumes $500M of synergies and $2B of opioid fines financed with debt, the analyst tells investors. Though such a deal would make financial sense, he does not think investors would "be overly excited about the strategic upside," Ransom tells investors. While he argues that LabCorp "offers more strategic upside," such a hypothetical deal also has less financial benefit, according to Ransom.

TODAY'S FREE FLY STORIES

EYE

National Vision

$32.05

0.35 (1.10%)

06:56
07/19/19
07/19
06:56
07/19/19
06:56
Hot Stocks
National Vision names Melissa Rasmussen as Chief Accounting Officer »

National Vision announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

06:55
07/19/19
07/19
06:55
07/19/19
06:55
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDFN

Redfin

$16.84

-0.74 (-4.21%)

06:54
07/19/19
07/19
06:54
07/19/19
06:54
Initiation
Redfin initiated  »

Redfin initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

LYB

LyondellBasell

$85.70

-0.03 (-0.03%)

06:52
07/19/19
07/19
06:52
07/19/19
06:52
Initiation
LyondellBasell initiated  »

LyondellBasell reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Z

Zillow

$48.20

0.08 (0.17%)

06:51
07/19/19
07/19
06:51
07/19/19
06:51
Initiation
Zillow initiated  »

Zillow initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:49
07/19/19
07/19
06:49
07/19/19
06:49
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

BLK

BlackRock

$474.98

4.06 (0.86%)

06:48
07/19/19
07/19
06:48
07/19/19
06:48
Hot Stocks
BlackRock CEO: People are underinvested in equities »

Says: Markets will trend…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

ATHM

Autohome

$82.03

-0.91 (-1.10%)

06:48
07/19/19
07/19
06:48
07/19/19
06:48
Downgrade
Autohome rating change  »

Autohome downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$38.78

0.15 (0.39%)

06:48
07/19/19
07/19
06:48
07/19/19
06:48
Hot Stocks
Schlumberger names Olivier Le Peuch as CEO, succeeding Paal Kibsgaard »

Schlumberger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

NWSA

News Corp.

$13.28

0.06 (0.45%)

06:47
07/19/19
07/19
06:47
07/19/19
06:47
Downgrade
News Corp. rating change  »

JPMorgan downgrades News…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$38.78

0.15 (0.39%)

06:46
07/19/19
07/19
06:46
07/19/19
06:46
Hot Stocks
Breaking Hot Stocks news story on Schlumberger »

Schlumberger names…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

MSGN

MSG Networks

$20.22

-0.31 (-1.51%)

06:43
07/19/19
07/19
06:43
07/19/19
06:43
Downgrade
MSG Networks rating change  »

MSG Networks downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

06:39
07/19/19
07/19
06:39
07/19/19
06:39
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$34.62

0.27 (0.79%)

06:39
07/19/19
07/19
06:39
07/19/19
06:39
Hot Stocks
Citizens Financial increases dividend 13% to 36c per share »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:38
07/19/19
07/19
06:38
07/19/19
06:38
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

CFG

Citizens Financial

$34.62

0.27 (0.79%)

06:36
07/19/19
07/19
06:36
07/19/19
06:36
Earnings
Citizens Financial reports Q2 EPS 96c, consensus 94c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

TSLA

Tesla

$253.82

-1.03 (-0.40%)

06:35
07/19/19
07/19
06:35
07/19/19
06:35
Recommendations
Tesla analyst commentary  »

Barclays forecasts much…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

, PANW

Palo Alto Networks

$222.31

-1.34 (-0.60%)

06:28
07/19/19
07/19
06:28
07/19/19
06:28
Recommendations
Crowdstrike, Palo Alto Networks analyst commentary  »

Crowdstrike price target…

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

PANW

Palo Alto Networks

$222.31

-1.34 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALT

Altimmune

$2.34

-0.1 (-4.10%)

06:25
07/19/19
07/19
06:25
07/19/19
06:25
Initiation
Altimmune initiated  »

Altimmune initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$206.26

2.14 (1.05%)

06:23
07/19/19
07/19
06:23
07/19/19
06:23
Hot Stocks
CME Group subsidiary completes first cleared inflation swap compression run »

TriOptima announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

ETFC

E-Trade

$46.50

0.78 (1.71%)

06:23
07/19/19
07/19
06:23
07/19/19
06:23
Recommendations
E-Trade analyst commentary  »

E-Trade price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

ALV

Autoliv

$69.88

0.04 (0.06%)

06:23
07/19/19
07/19
06:23
07/19/19
06:23
Earnings
Breaking Earnings news story on Autoliv »

Autoliv sees lower FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:22
07/19/19
07/19
06:22
07/19/19
06:22
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

ALV

Autoliv

$69.88

0.04 (0.06%)

06:22
07/19/19
07/19
06:22
07/19/19
06:22
Earnings
Autoliv reports Q2 adj. EPS $1.38, consensus $1.45 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

AAPL

Apple

$205.64

2.32 (1.14%)

06:19
07/19/19
07/19
06:19
07/19/19
06:19
Recommendations
Apple analyst commentary  »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 03

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.